Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on AnteoTech.
RELATED STOCKHEAD STORIES
News
ASX Small Cap Lunch Wrap: Who wasn’t invited to the party today?
Health & Biotech
ASX Health Stocks: Chimeric gets licence for CAR-T from U-Pen, Acrux gets nod from the FDA
Health & Biotech
ASX health stocks today: AdAlta (ASX:1AD) leads after successful Phase I study
Health & Biotech
Anteotech flags in-house scale up for its COVID-19 test kit, shares edge higher
News
Last Orders: Tech and energy stocks help the ASX closer higher
News
ASX Small Cap Lunch Wrap: Crypto dips on a cryptic tweet, ASX looks pretty sweet
Health & Biotech
Dr Boreham’s Crucible: Has Anteotech got Covid tests down to an ART form?
News
Last Orders: Sixth straight day of gains for small caps
Mining
Lithium prices continue to surge as graphite, cobalt take a breather
Health & Biotech
AnteoTech, Dotz Nano gain on progress on COVID tests
Health & Biotech
Check Up: Most health stocks have been feeling unwell, but Singular Health has tripled from IPO price
Health & Biotech
Check Up: A rough fortnight for healthcare as most lose ground
Tech
Chart of the Day: US Defense link boosts Anteotech (ASX:ADO) to 85pc rise
News
Last Orders: Best day in 12 weeks for ASX small caps
News
Last Orders: What you might have missed on the ASX today
News
Last Orders: What you might have missed today on the ASX
News
